Genetics Generation Advancement Corp. (4160.TWO)

TWD 70.2

(-2.9%)

Total Debt Summary of Genetics Generation Advancement Corp.

Genetics Generation Advancement Corp.'s latest annual total debt in 2023 was 49.29 Million TWD , up 1379.95% from previous year.
Genetics Generation Advancement Corp.'s latest quarterly total debt in 2024 Q2 was 45.36 Million TWD , up 172.38% from previous quarter.
Genetics Generation Advancement Corp. reported annual total debt of 3.33 Million TWD in 2022, up 37.76% from previous year.
Genetics Generation Advancement Corp. reported annual total debt of 2.41 Million TWD in 2021, down -76.43% from previous year.
Genetics Generation Advancement Corp. reported quarterly total debt of 45.36 Million TWD for 2024 Q2, up 172.38% from previous quarter.
Genetics Generation Advancement Corp. reported quarterly total debt of 49.29 Million TWD for 2023 FY, up 1379.95% from previous quarter.

Annual Total Debt Chart of Genetics Generation Advancement Corp. (2023 - 2019)

Historical Annual Total Debt of Genetics Generation Advancement Corp. (2023 - 2019)

Year	Total Debt	Total Debt Growth
2023	49.29 Million TWD	1379.95%
2022	3.33 Million TWD	37.76%
2021	2.41 Million TWD	-76.43%
2020	10.25 Million TWD	56.99%
2019	6.53 Million TWD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	16.65 Million TWD	-66.22%
2024 Q2	45.36 Million TWD	172.38%
2023 FY	49.29 Million TWD	1379.95%
2023 Q4	49.29 Million TWD	133.09%
2023 Q3	21.14 Million TWD	-12.92%
2023 Q2	24.28 Million TWD	91.84%
2023 Q1	12.66 Million TWD	0.0%
2022 Q4	- TWD	0.0%
2022 FY	3.33 Million TWD	37.76%
2021 FY	2.41 Million TWD	-76.43%
2020 FY	10.25 Million TWD	0.0%

Peer Total Debt Comparison of Genetics Generation Advancement Corp.

Name	Total Debt	Total Debt Difference
BIONET Corp.	45.01 Million TWD	-9.515%
DIVA Laboratories, Ltd.	2.53 Million TWD	-1846.959%
Welgene Biotech Co.,Ltd.	154.34 Million TWD	68.061%
Puriblood Medical Co., Ltd.	51.64 Million TWD	4.539%
TFBS Bioscience Inc.	131.77 Million TWD	62.589%